英文字典中文字典Word104.com



中文字典辭典   英文字典 a   b   c   d   e   f   g   h   i   j   k   l   m   n   o   p   q   r   s   t   u   v   w   x   y   z   







請輸入英文單字,中文詞皆可:

larger    音標拼音: [l'ɑrdʒɚ]
更大的

更大的

larger
較大

larger
adj 1: large or big relative to something else [synonym: {bigger},
{larger}]

Large \Large\ (l[aum]rj), a. [Compar. {Larger} (l[aum]r"j[~e]r);
superl. {Largest}.] [F., fr. L. largus. Cf. {Largo}.]
1. Exceeding most other things of like kind in bulk,
capacity, quantity, superficial dimensions, or number of
constituent units; big; great; capacious; extensive; --
opposed to {small}; as, a large horse; a large house or
room; a large lake or pool; a large jug or spoon; a large
vineyard; a large army; a large city.
[1913 Webster]

Note: For linear dimensions, and mere extent, great, and not
large, is used as a qualifying word; as, great length,
breadth, depth; a great distance; a great height.
[1913 Webster]

2. Abundant; ample; as, a large supply of provisions.
[1913 Webster]

We have yet large day. --Milton.
[1913 Webster]

3. Full in statement; diffuse; full; profuse.
[1913 Webster]

I might be very large upon the importance and
advantages of education. --Felton.
[1913 Webster]

4. Having more than usual power or capacity; having broad
sympathies and generous impulses; comprehensive; -- said
of the mind and heart.
[1913 Webster]

5. Free; unembarrassed. [Obs.]
[1913 Webster]

Of burdens all he set the Paynims large. --Fairfax.
[1913 Webster]

6. Unrestrained by decorum; -- said of language. [Obs.] "Some
large jests he will make." --Shak.
[1913 Webster]

7. Prodigal in expending; lavish. [Obs.] --Chaucer.
[1913 Webster]

8. (Naut.) Crossing the line of a ship's course in a
favorable direction; -- said of the wind when it is abeam,
or between the beam and the quarter.
[1913 Webster]

{At large}.
(a) Without restraint or confinement; as, to go at large;
to be left at large.
(b) Diffusely; fully; in the full extent; as, to discourse
on a subject at large.

{Common at large}. See under {Common}, n.

{Electors at large}, {Representative at large}, electors, or
a representative, as in Congress, chosen to represent the
whole of a State, in distinction from those chosen to
represent particular districts in a State. [U. S.]

{To give large}, {To go large}, {To run large}, or {To sail
large} (Naut.), to have the wind crossing the direction of a
vessel's course in such a way that the sails feel its full
force, and the vessel gains its highest speed. See
{Large}, a., 8.

Syn: Big; bulky; huge; capacious; comprehensive; ample;
abundant; plentiful; populous; copious; diffusive;
liberal.
[1913 Webster]

gr��er


請選擇你想看的字典辭典:
單詞字典翻譯
Larger查看 Larger 在Google字典中的解釋Google英翻中〔查看〕
Larger查看 Larger 在Yahoo字典中的解釋Yahoo英翻中〔查看〕





安裝中文字典英文字典查詢工具!


中文字典英文字典工具:
選擇顏色:
輸入中英文單字

































































英文字典中文字典相關資料:
  • Nonstatin Cholesterol Medications - NEXLIZET® NEXLETOL®
    NEXLIZET® NEXLETOL®, nonstatin cholesterol medications, approved to lower bad cholesterol reduce the risk of heart attack, stent placement bypass
  • U. S. FDA Approves Broad New Labels for NEXLETOL and . . . - DAIC
    April 1, 2024 — Esperion announced that the United States Food and Drug Administration (FDA) has approved broad new label expansions for NEXLETOL (bempedoic acid) Tablets and NEXLIZET (bempedoic acid and ezetimibe) Tablets based on positive CLEAR Outcomes data that include indications for cardiovascular risk reduction and expanded LDL-C lowering in both primary and secondary prevention
  • Broader Adoption of SGLT2 Inhibitors in Clinical Practice
    Over the past decade, the indications for sodium-glucose cotransporter 2 (SGLT2) inhibitors for kidney and cardiovascular risk reduction have expanded, driven by clinical trial evidence demonstrating their efficacy among individuals with chronic kidney disease (CKD), heart failure, diabetes, and
  • NEXLIZET® NEXLETOL® Other Outcomes Trial Information
    The most common adverse reactions in the cardiovascular outcomes trial for bempedoic acid, a component of NEXLIZET and NEXLETOL, at an incidence of ≥2% and 0 5% greater than placebo were hyperuricemia, renal impairment, anemia, elevated liver enzymes, muscle spasms, gout, and cholelithiasis
  • Esperion Showcases New Data from CLEAR Outcomes Highlighting . . .
    “These new analyses from CLEAR Outcomes further strengthen the evidence base supporting NEXLETOL as a proven therapy for cardiovascular risk reduction - especially for patients who cannot tolerate statin therapy,” said Sheldon Koenig, President and Chief Executive Officer of Esperion “The consistency of benefit observed in high-risk populations, including those with autoimmune or
  • FDA Expands Labels for Nexletol, Nexlizet to Prevent Heart . . .
    U S FDA approves broad new labels for Nexletol and Nexlizet to prevent heart attacks and cardiovascular procedures in both primary and secondary prevention patients, regardless of statin use
  • U. S. FDA Approves Broad New Labels for Esperion’s NEXLETOL . . .
    Esperion (NASDAQ: ESPR) today announced that the United States Food and Drug Administration (FDA) has approved broad new label expansions for NEXLETOL ® (bempedoic acid) Tablets and NEXLIZET ® (bempedoic acid and ezetimibe) Tablets based on positive CLEAR Outcomes data that include indications for cardiovascular risk reduction and expanded LDL-C lowering in both primary and secondary
  • U. S. FDA Approves Broad New Labels for Esperion’s NEXLETOL . . .
    U S FDA approves broad new labels for NEXLETOL® (bempedoic acid) Tablets and NEXLIZET® (bempedoic acid and ezetimibe) Tablets to prevent heart attacks and cardiovascular procedures in both primary and secondary prevention patients, regardless of statin use
  • In brief: Cardiovascular outcomes with bempedoic acid (Nexletol)
    In brief: Cardiovascular outcomes with bempedoic acid (Nexletol) Med Lett Drugs Ther 2023 Apr 17;65 (1674):62-63 doi: 10 58347 tml 2023 1674b
  • SGLT2 Inhibitors: What They Are, Uses Side Effects
    SGLT2 inhibitors also lower the risk of heart failure flare-ups How do SGLT2 inhibitors work? SGLT2 is a protein in your kidneys that reabsorbs glucose Typically, when glucose in your blood flows through your kidneys, some glucose goes back into your bloodstream These medications block that process, so your kidneys don’t reabsorb glucose





中文字典-英文字典  2005-2009

|中文姓名英譯,姓名翻譯 |简体中文英文字典